 Transactions to create a precision genetic medicine company focused on neuromuscular and cardiac rare diseases CHARLESTOWN, Mass., Dec. 01, 2022 GLOBE NEWSWIRE Solid Biosciences Inc. Nasdaq: SLDB, a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy Duchenne, today announced the results of the special meeting of the stockholders ... The post Solid Biosciences Announces Stockholder Approval of Acquisition of AavantiBio appeared first on Fo... 